Abstract
Statins reduce the risk of cardiovascular events in people with hypertension. This benefit could arise from a beneficial effect of statins on central aortic pressures and hemodynamics. The Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) study, an Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) substudy, investigated this hypothesis in a prospective placebo-controlled study of treated patients with hypertension.
Original language | English |
---|---|
Pages (from-to) | 53-61 |
Number of pages | 9 |
Journal | Circulation (Baltimore) |
Volume | 119 |
Issue number | 1 |
DOIs | |
Publication status | Published - 13 Jan 2009 |